Literature DB >> 9888257

Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.

J Duarte1, C Lugnier, A I Torres, F Pérez-Vizcaino, A Zarzuelo, J Tamargo.   

Abstract

1. Visnagin relaxed aortae previously contracted by noradrenaline. This effect was unalterated by endothelium removal and potentiated, at high concentrations, by the previous incubation with sodium nitroprusside. 2. Visnagin weakly inhibited the hydrolytic activity of the cyclic nucleotide phosphodiesterase (PDE) isozymes (PDE5, PDE4, PDE3, cyclic GMP activated PDE2 and PDE1). 3. The present results indicate an involvement of PDE inhibition in the relaxant effect of visnagin at high concentration (>5x10(-5) M).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888257     DOI: 10.1016/s0306-3623(98)00083-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.

Authors:  Lei Xi
Journal:  Ann Transl Med       Date:  2016-02

2.  Development of a fission yeast-based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases.

Authors:  F Douglas Ivey; Lili Wang; Didem Demirbas; Christina Allain; Charles S Hoffman
Journal:  J Biomol Screen       Date:  2008-01

3.  Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis.

Authors:  Hai-Rong Fu; Xiao-Shan Li; Yong-Hui Zhang; Bin-Bin Feng; Lian-Hong Pan
Journal:  Eur J Histochem       Date:  2020-09-07       Impact factor: 3.188

Review 4.  Ammi Visnaga L., a Potential Medicinal Plant: A Review.

Authors:  Noha Khalil; Mokhtar Bishr; Samar Desouky; Osama Salama
Journal:  Molecules       Date:  2020-01-12       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.